These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
138 related articles for article (PubMed ID: 35917982)
21. Enhanced anti-tumor activity of trichosanthin after combination with a human-derived cell-penetrating peptide, and a possible mechanism of activity. Lu YZ; Li PF; Li YZ; Luo F; Guo C; Lin B; Cao XW; Zhao J; Wang FJ Fitoterapia; 2016 Jul; 112():183-90. PubMed ID: 27050721 [TBL] [Abstract][Full Text] [Related]
22. Customizing a Tridomain TRAIL Variant to Achieve Active Tumor Homing and Endogenous Albumin-Controlled Release of the Molecular Machine In Vivo. Tao Z; Liu Y; Yang H; Feng Y; Li H; Shi Q; Li S; Cheng J; Lu X Biomacromolecules; 2020 Oct; 21(10):4017-4029. PubMed ID: 32804484 [TBL] [Abstract][Full Text] [Related]
23. Recombinant production of interleukin-1 receptor antagonist in fusion to albumin binding domain with potential affinity to human serum albumin. Shafiee F; Yazdani A Res Pharm Sci; 2024 Jun; 19(3):356-365. PubMed ID: 39035819 [TBL] [Abstract][Full Text] [Related]
24. Preclinical Evaluation of HER2-Targeting DARPin G3: Impact of Albumin-Binding Domain (ABD) Fusion. Deyev SM; Oroujeni M; Garousi J; Gräslund T; Li R; Rosly AHB; Orlova A; Konovalova E; Schulga A; Vorobyeva A; Tolmachev V Int J Mol Sci; 2024 Apr; 25(8):. PubMed ID: 38673831 [TBL] [Abstract][Full Text] [Related]
25. Trichosanthin induces leakage and membrane fusion of liposome. Xia XF; Zhang F; Shaw PC; Sui SF IUBMB Life; 2003 Dec; 55(12):681-7. PubMed ID: 14769004 [TBL] [Abstract][Full Text] [Related]
26. A Sixty-Year Research and Development of Trichosanthin, a Ribosome-Inactivating Protein. Lu JQ; Wong KB; Shaw PC Toxins (Basel); 2022 Feb; 14(3):. PubMed ID: 35324675 [TBL] [Abstract][Full Text] [Related]
27. [Gene cloning, expression and purification of fusion protein epidermal growth factor-linker-trichosanthin]. Li YM; Yang HW; Luo R Nan Fang Yi Ke Da Xue Xue Bao; 2007 Feb; 27(2):205-7. PubMed ID: 17355938 [TBL] [Abstract][Full Text] [Related]
28. Interaction between trichosanthin, a ribosome-inactivating protein, and the ribosomal stalk protein P2 by chemical shift perturbation and mutagenesis analyses. Chan DS; Chu LO; Lee KM; Too PH; Ma KW; Sze KH; Zhu G; Shaw PC; Wong KB Nucleic Acids Res; 2007; 35(5):1660-72. PubMed ID: 17308345 [TBL] [Abstract][Full Text] [Related]
29. Enhanced green fluorescence protein tracks trichosanthin in human choriocarcinoma cells as a feasible and stable reporter. Wang Y; Mi SL; Lou MY; Gao Y; Chen ZL; An CC Front Biosci; 2005 Sep; 10():2279-84. PubMed ID: 15970494 [TBL] [Abstract][Full Text] [Related]
30. Anti-HIV agent trichosanthin enhances the capabilities of chemokines to stimulate chemotaxis and G protein activation, and this is mediated through interaction of trichosanthin and chemokine receptors. Zhao J; Ben LH; Wu YL; Hu W; Ling K; Xin SM; Nie HL; Ma L; Pei G J Exp Med; 1999 Jul; 190(1):101-11. PubMed ID: 10429674 [TBL] [Abstract][Full Text] [Related]
31. [A comparative study on the properties of trichosanthin before and after site-directed PEGylation]. An QX; Lei YF; Mu SJ; Zhang XQ; Chen R; Xia AJ; Chen C; Yi J; Wu YR; Yu R; Xu ZK Zhonghua Yi Xue Za Zhi; 2008 May; 88(20):1433-6. PubMed ID: 18953888 [TBL] [Abstract][Full Text] [Related]
32. Independency of anti-HIV-1 activity from ribosome-inactivating activity of trichosanthin. Wang JH; Nie HL; Huang H; Tam SC; Zheng YT Biochem Biophys Res Commun; 2003 Feb; 302(1):89-94. PubMed ID: 12593852 [TBL] [Abstract][Full Text] [Related]
33. Fusion to a highly stable consensus albumin binding domain allows for tunable pharmacokinetics. Jacobs SA; Gibbs AC; Conk M; Yi F; Maguire D; Kane C; O'Neil KT Protein Eng Des Sel; 2015 Oct; 28(10):385-93. PubMed ID: 26275855 [TBL] [Abstract][Full Text] [Related]
34. Expression and bioactivity of recombinant human serum albumin and dTMP fusion proteins in CHO cells. Ru Y; Zhi D; Guo D; Wang Y; Li Y; Wang M; Wei S; Wang H; Wang N; Che J; Li H Appl Microbiol Biotechnol; 2016 Sep; 100(17):7565-75. PubMed ID: 27115755 [TBL] [Abstract][Full Text] [Related]
35. Site-directed PEGylation of trichosanthin retained its anti-HIV activity with reduced potency in vitro. Wang JH; Tam SC; Huang H; Ouyang DY; Wang YY; Zheng YT Biochem Biophys Res Commun; 2004 May; 317(4):965-71. PubMed ID: 15094363 [TBL] [Abstract][Full Text] [Related]
36. Induced apoptotic action of recombinant trichosanthin in human stomach adenocarcinoma MCG803 cells. Xu J; Gao DF; Yan GL; Fan JM Mol Biol Rep; 2009 Jul; 36(6):1559-64. PubMed ID: 18773305 [TBL] [Abstract][Full Text] [Related]
37. Smac is another pathway in the anti-tumour activity of Trichosanthin and reverses Trichosanthin resistance in CaSki cervical cancer cells. Cui L; Song J; Wu L; Huang L; Wang Y; Huang Y; Yu H; Huang Y; You CC; Ye J Biomed Pharmacother; 2015 Feb; 69():119-24. PubMed ID: 25661347 [TBL] [Abstract][Full Text] [Related]
38. The structural basis of Trp192 and the C-terminal region in trichosanthin for activity and conformational stability. Ding Y; Too H; Wang Z; Liu Y; Bartlam M; Dong Y; Wong K; Shaw P; Rao Z Protein Eng; 2003 May; 16(5):351-6. PubMed ID: 12826726 [TBL] [Abstract][Full Text] [Related]
39. Exploring a novel long-acting glucagon-like peptide-1 receptor agonist built on the albumin-binding domain and XTEN scaffolds. Zhou Y; Li J; Gao G; Li Y; Zhang C Heliyon; 2024 Jan; 10(2):e24340. PubMed ID: 38293540 [TBL] [Abstract][Full Text] [Related]
40. A novel trichosanthin fusion protein with increased cytotoxicity to tumor cells. Lin B; Yang XZ; Cao XW; Zhang TZ; Wang FJ; Zhao J Biotechnol Lett; 2017 Jan; 39(1):71-78. PubMed ID: 27714558 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]